DMSO-PDT of BCC - A 6 Year Follow up

Carcinoma, Basal Cell Clinical Trial

Official title:

Dimethylsulphoxide-supported Photodynamic Therapy of Basal Cell Carcinoma Combined With Curettage - A 6 Year Clinical and Histological Evaluation.

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00218829
• Other study ID #: EC-002
• Status: Completed
• Phase: N/A
• First received: September 20, 2005
• Last updated: March 10, 2017
• Start date: September 1997
• Est. completion date: December 2004

Study information

• Verified date: March 2017
• Source: Norwegian University of Science and Technology
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to registrate long time clinical and histological treatment response of basal cell carcinoma (BCC) lesions treated with one or two procedures of dimethylsulfoxide supported 5-aminolaevulinic acid photodynamic therapy (DMSO-PDT).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 44
• Est. completion date: December 2004
• Est. primary completion date: December 2004
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• histological verified bcc.

• one or two PDT treatments with treatment interval no longer than two weeks.

• lesion complete response three months after therapy.

Exclusion Criteria:

• pregnant.

• Gorlin's syndrome.

• morpheaform or pigmented bcc.

• histology older than one year.

• tumour infiltration more than four mm.

• previous PDT treated lesions.

Related Conditions & MeSH terms

• Carcinoma
• Carcinoma, Basal Cell

Locations

Country	Name	City	State
n/a

Sponsors (2)

Lead Sponsor	Collaborator
Norwegian University of Science and Technology	St. Olavs Hospital

References & Publications (1)

Christensen E, Skogvoll E, Viset T, Warloe T, Sundstrøm S. Photodynamic therapy with 5-aminolaevulinic acid, dimethylsulfoxide and curettage in basal cell carcinoma: a 6-year clinical and histological follow-up. J Eur Acad Dermatol Venereol. 2009 Jan;23(1 — View Citation